Abstract-We tested the hypothesis that transient receptor potential canonical type 3 (TRPC3) channels are increased in vascular smooth muscle cells and aortic tissue from spontaneously hypertensive rats (SHR) compared with normotensive Wistar Kyoto rats. Expression of TRPC3 was analyzed by immunohistochemistry and Western blotting. TRPC3 gene knockdown was performed by specific small interfering RNA and TRPC3 overexpression using the pAdEasy-1 system. Cytosolic calcium was measured using fluorescence spectrophotometry and vasoconstriction of aortic rings using a force transducer. In SHR, the expression of TRPC3 channel protein was significantly higher in aortic rings ( 
T ransient receptor potential canonical (TRPC) are nonselective cation channels that had been identified in several tissues, including heart and vascular smooth muscle cells (VSMC). TRPC type 3 (TRPC3) channels play an important role in several cardiovascular diseases and probably hypertension. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] An increased TRPC3 expression could be demonstrated in peripheral monocytes from spontaneously hypertensive rats (SHR) compared with normotensive Wistar Kyoto rats (WKY). 5, 6 Dietrich et al reported that TRPC6 knockout mice showed elevated TRPC3 channel expression, increased vasoconstriction, and increased blood pressure. 7 Increased angiotensin II-induced vasoconstriction and proliferation of VSMC, as well as augmented angiotensin II-induced intracellular signal transduction pathways and calcium influx, have frequently been observed in primary hypertension. 6, [11] [12] [13] [14] [15] Part of the action of angiotensin II may occur through TRPC channels. Although data from the literature gave evidence that calcium influx through TRPC3 channels may contribute to vasoconstriction and hypertension, this has not been tested yet using VSMC from SHR. In the present study, we tested the hypothesis that calcium influx through TRPC3 is increased in VSMC and aortic tissue from SHR compared with WKY.
Methods
A detailed description of the Methods can be found in an online supplement available at http://hyper.ahajournals.org.
Animals (SHR and WKY), interventions and hemodynamic measurements, preparation of aortic rings and vasoconstriction, 16, 17 culture of VSMC, measurements of cytosolic calcium concentration, 18, 19 RNA isolation and RT-PCR, and immunoblottings and immunohistochemistry had been described previously by our group. All experiments were performed as approved by the animal care and use committee. The TRP channel blocker SKF-96365 (Merck Biosciences; final concentration 10 mol/L) was used. 20 -22 Changes of cytosolic calcium were reported as described. 23 Antibodies were purchased from Alomone Labs (Jerusalem, Israel), 5, 24, 25 or Santa Cruz Biotechnology (Santa Cruz, Calif). Small interfering RNA knockdown was performed using silencer small interfering RNA transfection kit (Ambion; Austin, Tex). Overexpression of TRPC3 channels was done using pAdEasy-1 system.
Statistical Analysis
All results are expressed as the meanϮSEM of Ն3 independent experiments. Data were compared using 2-tailed Student t test or ANOVA and Tukey's multiple comparisons post hoc test as appropriate. Two-sided P values Ͻ0.05 were considered significant. Where error bars do not appear on the figures, error was within the symbol size.
Results

Identification of TRPC in the Vasculature
First, we used RT-PCR to show the presence of TRPC3 transcripts in vasculature from adult normotensive WKY, 5-week-old prehypertensive SHR (preSHR), and adult SHR. Calculating the TRPC3/GAPDH ratio indicated that TRPC3 transcripts were significantly more expressed in vasculature from adult SHR compared with adult WKY or preSHR (each PϽ0.05; Figure 1A ).
Second, we identified TRPC3 channel proteins in VSMC from SHR and normotensive WKY using specific antibodies and immunohistochemistry ( Figure 1B ). Figure 2A ) from SHR compared with WKY. In contrast, the expression of angiotensin II type 1 receptor (AT1R) protein was not significantly different in aortic rings from SHR and WKY (1.13Ϯ0.03 versus 1.00Ϯ0.06; each nϭ6; PϭNS; Figure 2B ).
Increased Expression of TRPC3 Channel Protein in Aortic Tissue From SHR
Increased Expression of TRPC3 Channel Protein in VSMC From SHR
The expression of TRPC3 channel protein was significantly elevated in VSMC from SHR compared with WKY (1.28Ϯ0.08 versus 1.00Ϯ0.03; each nϭ6; PϽ0.05; Figure  2C ). In contrast, the expression of AT1R protein was not significantly different in VSMC from SHR and WKY (1.14Ϯ0.06 versus 1.00Ϯ0.05; each nϭ6; PϾ0.05; Figure  2D ). In additional experiments, we established that TRPC3 channel protein expression was not affected by cell culture by comparing TRPC3 channel protein expression in freshly isolated cells and cultured VSMC from the third and tenth passage. As shown in Figure 2E for WKY (freshly isolated cells 1.05Ϯ0.12; third passage 1.09Ϯ0.05; tenth passage 1.06Ϯ0.06; each nϭ3; PϭNS) and Figure 2F for SHR (freshly isolated cells 1.22Ϯ0.10; third passage 1.27Ϯ0.07; tenth passage 1.21Ϯ0.11; each nϭ3; PϭNS), TRPC3 channel protein expression was not affected by cell culture.
As indicated in Figure 2G and 2H, both systolic blood pressure and the expression of TRPC3 channel protein in aortic tissue from adult SHR were significantly higher compared with 5-week-old preSHR or with adult WKY. Now, we investigated whether the increased TRPC3 channel protein expression in SHR was associated with enhanced angiotensin II-induced elevation of blood pressure, vasoconstriction, and calcium increase in SHR. The intravenous injection of angiotensin II at a rate of 24 g/kg per hour for 60 minutes increased mean arterial blood pressure in rats. The angiotensin II-induced elevation of arterial blood pressure was significantly higher in SHR compared with WKY (53Ϯ3 mm Hg versus 22Ϯ4 mm Hg; each nϭ6; PϽ0.05).
Furthermore, angiotensin II-induced aortic contraction was significantly higher in SHR compared with WKY (82Ϯ3% of maximal potassium contraction versus 54Ϯ6% of maximum potassium contraction; each nϭ6; PϽ0.01). Additional experiments showed that compared with control conditions (100Ϯ8%; nϭ12), the administration of calcium channel blocker amlodipine significantly reduced the angiotensin II-induced contraction to 72Ϯ7% (nϭ9; PϽ0.05), whereas Figure 3A ). As indicated in Figure 3A , the angiotensin II-induced aortic contraction was also significantly higher in SHR compared with WKY in the presence of amlodipine but not in the presence of SKF-96365. Baseline cytosolic calcium concentration was similar in VSMC from SHR and WKY (103Ϯ12 versus 99Ϯ9 nmol/L, respectively; each nϭ6; PϭNS).
The angiotensin II-induced calcium increase was significantly enhanced in VSMC from SHR compared with WKY (increase of cytosolic calcium 229Ϯ10 versus 115Ϯ13 nmol/L, respectively; PϽ0.01). In the presence of calcium channel blocker amlodipine, the angiotensin II-induced calcium influx was still significantly higher in VSMC from SHR compared with WKY (170Ϯ10 versus 130Ϯ12 nmol/L, respectively; PϽ0.01). In contrast, in the presence of the TRP cation channel blocker SKF-96365, the angiotensin IIcalcium-influx was similar in VSMC from SHR and WKY (126Ϯ13 versus 113Ϯ10 nmol/L, respectively; PϭNS by ANOVA and Tukey's multiple comparisons post hoc test; Figure 3B ).
Using TRPC3 channel protein overexpression, we confirmed that an increased TRPC3 channel protein expression in VSMC caused elevated angiotensin II-induced calcium influx, whereas TRPC3 gene knockdown in VSMC reduced TRPC3 expression and caused reduced angiotensin II-induced calcium influx. Transfecting TRPC3 gene into cultured VSMC from SHR significantly increased TRPC3 channel protein expression from 100Ϯ4% to 167Ϯ4% (nϭ6; PϽ0.01; Figure 4A ) and hence significantly elevated the angiotensin II-induced calcium increase by 55Ϯ4% (nϭ6; PϽ0.01; Figure 4B ). Specific small interfering RNA against TRPC3 significantly reduced TRPC3 channel protein expression in cultured VSMC from SHR from 100Ϯ11% to 49Ϯ4% (nϭ3; PϽ0.05; Figure 4C ), whereas TRPC6 channel protein expression was not affected (100Ϯ18% versus 99Ϯ16%; PϭNS; Figure 4D ). The reduction of TRPC3 channel protein expression in VSMC significantly reduced the angiotensin II-induced calcium increase by 36Ϯ3% (nϭ5; PϽ0.05; Figure 4E ).
Next, we determined whether angiotensin directly increases the expression of TRPC3 channel protein in VSMC. To this end, VSMC from SHR or WKY were cultured in the continuous presence of 100 nmol/L angiotensin II throughout culturing. The administration of angiotensin II significantly elevated the expression of TRPC3 channel protein in VSMC from SHR from 1.28Ϯ0.08 to 1.61Ϯ0.08 (each nϭ6; PϽ0.01) but only slightly changed TRPC3 channel protein expression in VSMC from WKY from 1.00Ϯ0.03 to 1.11Ϯ0.07 (each nϭ6; PϭNS; Figure 5A ). As indicated in Figure 5B , the administration of the AT1R antagonist telmisartan prevented the angiotensin II-induced TRPC3 channel protein expression in VSMC from SHR (0.74Ϯ0.05 versus 1.61Ϯ0.08; each nϭ6; PϽ0.01).
These data indicated that angiotensin II increased the expression of TRPC3 channel protein in VSMC from SHR in vitro, and this effect could be blocked by the AT1R antagonist telmisartan. Now, we investigated whether the effects of telmisartan on TRPC3 channel protein expression could also be observed in vivo. To support the hypothesis that blocking of angiotensin II but not reduction of blood pressure per se affects TRPC3 channel protein expression in VSMC, we also used the calcium channel blocker amlodipine in SHR. SHR were randomly allocated to placebo, telmisartan (5 mg/kg per day), or amlodipine (10 mg/kg per day), which was administered for 4 weeks. Compared with placebo (201Ϯ5 mm Hg; nϭ6), the administration of telmisartan significantly reduced blood pressure to 124Ϯ8 mm Hg (nϭ6), whereas amlodipine significantly reduced blood pressure to 116Ϯ5 mmHg (nϭ5; each PϽ0.01 compared with placebo by ANOVA and Tukey's multiple comparisons post hoc test; Figure 6A ). Furthermore, the angiotensin II-induced vasoconstriction of aortic rings was significantly lower in the telmisartan group compared with the placebo group (30Ϯ8% versus 82Ϯ3%; each nϭ6; PϽ0.01). Most important, compared with placebo, telmisartan significantly reduced TRPC3 channel protein expression from 1.00Ϯ0.07 to 0.32Ϯ0.20 (each nϭ3; PϽ0.05 by ANOVA and Tukey's multiple comparisons post hoc test), whereas TRPC3 channel protein expression was unchanged in the amlodipine group (1.30Ϯ0.15; nϭ3; PϭNS; Figure 6B ).
Discussion
This report is the first to give experimental evidence for the importance of increased TRPC3 channel protein expression in the vasculature for elevated blood pressure in SHR. Foremost, for the first time, our present study showed an increased TRPC3 channel protein expression in the vasculature from adult SHR compared with adult WKY. In line with these findings, we observed increased TRPC3 transcripts in the vasculature from SHR compared with WKY. Furthermore, we showed that TRPC3 channel protein expression in the vasculature from 5-week-old prehypertensive SHR was similar to normotensive WKY. Second, for the first time, this study reported that TRPC3 channel proteins are regulated by angiotensin II in VSMC from SHR. Third, for the first time, this study showed that the long-term administration of telmisartan (but not amlodipine) to hypertensive rats reduces TRPC3 channel protein expression, confirming the importance of TRPC3 channel protein regulation by angiotensin II in vivo as well. However, additional electrophysiological data are needed to support these results.
The increased expression of TRPC3 was associated with enhanced angiotensin II-induced elevation of blood pressure, enhanced angiotensin II-induced vasoconstriction, and enhanced angiotensin II-induced calcium influx in VSMC from SHR. The hyper-responsiveness of vessels and VSMC from SHR after angiotensin II stimulation has been demonstrated clearly by several groups. 6,12-15 Our present findings support previous results from several groups showing an increased 
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angiotensin II-induced calcium influx in VSMC from SHR. [12] [13] [14] [15] Although major calcium influx in VSMC is mediated by voltage-gated calcium channels, TRPC channels are important signal transducers for agonist-mediated vascular contractility. It should be noted that the increased angiotensin II-induced calcium influx in primary hypertension could also be observed in the presence of the calcium channel blocker amlodipine. On the other hand, in the presence of the nonselective TRP cation channel blocker SKF-96365, the angiotensin II-induced calcium influx was similar in VSMC from SHR and WKY. Furthermore, in SHR, the angiotensin II-induced calcium influx was considerably more reduced in the presence of SKF-96365 compared with amlodipine, supporting an important role of calcium influx through TRP channels in SHR. Use of SKF-96365 has been validated to block TRP cation channels by several investigators. 20 -22 SHR is a wellknown animal model of hypertension showing no significant differences of AT1R expression compared with WKY. 26 -28 We gave experimental evidence that TRPC3 channels are directly involved in angiotensin II-induced calcium influx. TRPC3 overexpression in VSMC increased the angiotensin II-induced calcium influx, whereas TRPC3 gene knockdown reduced angiotensin II-induced calcium influx in VSMC. In accordance with these results, Kaznacheyeva et al recently showed that downregulation of TRPC3 reduces calcium influx after depletion of intracellular stores in A431 cells. 29 Second, the administration of angiotensin II significantly elevated the expression of TRPC3 in VSMC from SHR but not from WKY, supporting the proliferative action of angiotensin II in hypertension. Third, the administration of the AT1R antagonist telmisartan prevented the angiotensin IIinduced elevation of TRPC3 expression in cultured VSMC from SHR in vitro. Long-term administration of telmisartan significantly reduced blood pressure, vasoconstriction, and most important, TRPC3 expression, in aortic tissue in vivo.
On the other hand, we showed that the reduction of blood pressure using amlodipine did not significantly change TRPC3 expression in vasculature. In line with these results, Kogata et al reported that long-term treatment with telmisartan but not amlodipine improved the acetylcholine-induced vessel relaxation in hypertensive rats, although blood pressure reduction was similar in both groups. 30 The observed reduction of TRPC3 after administration of telmisartan but not amlodipine may also explain in part the protective effects of AT1 antagonists in hypertension beyond blood pressure reduction as indicated by recent literature. The AT1 receptor antagonists irbesartan and candesartan but not amlodipine treatment showed beneficial effects in diabetic apolipoprotein E-null mouse or monkeys. [31] [32] 
Perspectives
We observed an increased TRPC3 cation channel expression in vasculature from SHR compared with WKY, which was associated with increased contraction, an increased angiotensin II-induced TRPC3 expression, and finally, the reduction of TRPC3 expression after administration of telmisartan but not amlodipine in vivo. These results add to a considerable body of evidence that TRP channels are involved in vasoregulatory mechanisms. 33 Furthermore, the present results point to the relevance of TRPC3 in the pathogenesis of primary hypertension. As indicated by recent literature, expression of several TRP channel subtypes may be divergent and redundant in cardiovascular diseases. Moreover, TRP channels display diverse properties, localization, and regulation as a result of their assembly into distinct homomeric and heteromeric channel complexes. 34 However, TRP channels will be fascinating targets to elucidate novel pathogenic mechanisms in hypertension, and TRP channels will be new therapeutic targets for cure of hypertension. The effect of long term administration of the angiotensin II receptor 1 (AT1R) antagonist telmisartan or the calcium channel blocker amlodipine on blood pressure and TRPC3 expression was investigated in SHR. SHR were randomly allocated to the groups. Telmisartan (5mg/kg/day), amlodipine (10mg/kg/day), or placebo was given by gavage for 4 weeks.
Sources of Funding
Systolic blood pressure which was measured by tail-cuff plethysmography and body weights were quantified every week. At the end of 4 weeks, the rats were killed by decapitation and aorta was used for measurements.
Preparation of aortic rings and vasoconstriction
The thoracic aorta was dissected, carefully freed from connective tissue, and placed in Krebs immunocytochemical localization of smooth muscle-specific α-actin was performed using monoclonal antibodies ASM-1 raised against smooth muscle α-actin. A viability of VSMC more than 95% was observed by trypan blue exclusion.
Measurement of cytosolic calcium concentration
Cytosolic calcium concentration was measured in cultured VSMC using the fluorescent dye technique as previously described by our group. The PCR products were size fractionated on 1.5% agarose gels, and DNA was visualized by ethidium bromide staining using an imaging analyzer (GelDoc 2000，BioRad，Germany).
The expected product sizes were 442bp for TRPC3 and 231bp for GAPDH, respectively.
Western blotting
Immunoblottings of TRPC3 and AT1R were performed using standard techniques. Over-expression of TRPC3 using pAdEasy-1 system
The cDNA encoding human TRPC3 was amplified by RT-PCR from TRPC3pcDNA3. Immunohistochemistry Cultured VSMC were fixed with 10% formalin for 10minutes at room temperature, washed with phosphate buffered saline (PBS) and then permeabilized with PBS containing 0.5%
Triton X-100 for 20 minutes at room temperature. VSMC were incubated with PBS containing with 5% bovine serum and 0.1% Triton X-100 for 1hour at room temperature.
Then VSMC were incubated with rabbit anti-TRPC3 antibody (1:200, alomone) over night at 4°C. VSMC were then washed and incubated with antibodies conjugated to a fluorescent probe (FITC-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, USA), 1:200 for 30minutes at room temperature. In control experiments, the primary antibodies were preincubated for 12h at 4°C with antigenic peptide (1:25) . After removing the unbound secondary antibodies by washing the preparations with PBS, imaging was performed using the fluorescence microscope (NiKon, TE2000).
Statistical analysis
All results are expressed as the mean±SEM of at least 3 independent experiments. Data were compared using two-tailed Student's t-test or ANOVA and Tukey's multiple comparisons post hoc test as appropriate. Two-sided p values less than 0.05 were considered significant. Where error bars do not appear on the figure, error was within the symbol size.
